Tianjin TEDA Biomedical Engineering Co Ltd
Company Profile
Business description
Tianjin TEDA Biomedical Engineering Co Ltd is engaged in the research, development, and commercialization of biological compound fertilizers, providing elderly and health care services. It operates in two segments namely; biological compound fertilizers products, and elderly care and health care services. The company generates a majority of its revenue from the Fertilisers products segment which is engaged in manufacturing and selling biological compound fertiliser products, including active fertiliser, mixture with nitrogen, phosphorus, and potassium with various formulas, providing warehousing services, and processing and licensing of the fertiliser products. The People's Republic of China is the primary geographical market for the company.
Contact
No. 80, The 4th Avenue
9th Floor, Block A2, Tianda Hi-Tech Park
TEDA Tianjin
Tianjin
CHNT: +86 2259816900
Sector
Basic Materials
Stock type
Cyclical
Industry
Agricultural Inputs
Fiscal Year End
31 December 2025
Employees
260
Stocks News & Analysis
stocks
Strong finish to the year for overvalued ASX share
stocks
Our three most overvalued ASX shares
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,071.60 | 48.90 | -0.54% |
| CAC 40 | 7,734.84 | 60.06 | 0.78% |
| DAX 40 | 23,807.13 | 210.15 | 0.89% |
| Dow JONES (US) | 45,514.95 | 114.09 | 0.25% |
| FTSE 100 | 9,221.44 | 13.23 | 0.14% |
| HKSE | 25,839.36 | 205.45 | 0.80% |
| NASDAQ | 21,798.70 | 98.31 | 0.45% |
| Nikkei 225 | 43,699.76 | 55.95 | 0.13% |
| NZX 50 Index | 13,239.63 | 41.51 | -0.31% |
| S&P 500 | 6,495.15 | 13.65 | 0.21% |
| S&P/ASX 200 | 8,794.40 | 46.50 | -0.53% |
| SSE Composite Index | 3,815.61 | 11.24 | -0.29% |